Li Jen Chen
Directeur Général chez HUMORIGIN BIOTECHNOLOGY CORP
Profil
Li Jen Chen is currently the General Manager at TriArm Therapeutics (Taiwan) Ltd.
They have a background in undergraduate and graduate studies from National Taiwan University and Case Western Reserve University School of Law.
Postes actifs de Li Jen Chen
Sociétés | Poste | Début |
---|---|---|
HUMORIGIN BIOTECHNOLOGY CORP | Directeur Général | 31/12/2013 |
Formation de Li Jen Chen
National Taiwan University | Graduate Degree |
Case Western Reserve University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
TriArm Therapeutics (Taiwan) Ltd.
TriArm Therapeutics (Taiwan) Ltd. BiotechnologyHealth Technology TriArm Therapeutics (Taiwan) Ltd. engages in the research and development of biotech new drugs. It develops drugs for cancer immunotherapy including melanoma, leukemia, and breast cancer; monoclonal antibody drugs for anti-inflammatory including sepsis, rare diseases, and multiple sclerosis; and anti-influenza drugs. The Company was founded on December 11, 2002 and is headquartered in New Taipei, Taiwan. | Health Technology |